Postpartum Low-Dose Esketamine Aids Moms With Prenatal Depression

MONDAY, April 15, 2024 -- A single low dose of esketamine after childbirth reduces depressive episodes at 42 days postpartum among mothers with prenatal depression, according to a study published online April 10 in The BMJ. Shuo Wang, M.D., from...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news